Recommendations for the management of over-anticoagulation with warfarin.
Isbister
G K
GK
Department of Clinical Toxicology and Pharmacology, Newcastle Mater Hospital, Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, Australia. gbsbite@bigpond.com
Dawson
A
A
Isbister
J P
JP
D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage / Q000506:poisoning*; D016913:Blood Component Transfusion; D062787:Drug Overdose; D006470:Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D006801:Humans; D019934:International Normalized Ratio / Q000379:methods; D010949:Plasma; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D014812:Vitamin K / Q000627:therapeutic use; D014859:Warfarin / Q000008:administration & dosage / Q000506:poisoning*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin